Fig. 10From: Evaluation of the anticancer potential of CD44 targeted vincristine nanoformulation in prostate cancer xenograft model: a multi-dynamic approach for advanced pharmacokinetic evaluationGraphs plotted for different concentrations (µg/ml) for vincristine injection compared to NFs of VC-loaded TCs-HA. The prepared nanoformulations showed an improved area under peak at time points and provided sustained release of the drug for a longer timeBack to article page